EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust

Ashish Kumar, Michael A Nader, Gagan Deep

Pharmacological Reviews · 2024-03 · 76 (2) · 199-227

DOI: 10.1124/pharmrev.122.000788 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Reviews, 2024-03. Verfasst von Ashish Kumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Cancer Biology (A.K., G.D.), Physiology and Pharmacology (M.A.N.), Radiology (M.A.N.), and Center for Addiction Research (M.A.N., G.D.…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Extracellular Vesicles, Alzheimer Disease. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 330 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDA NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) have emerged as an attractive liquid biopsy approach in the diagnosis and prognosis of multiple diseases and disorders. The feasibility of enriching specific subpopulations of EVs from biofluids based on their unique surface markers has opened novel opportunities to gain molecular insight from various tissues and organs, including the brain. Over the past decade, EVs in bodily fluids have been extensively studied for biomarkers associated with various neurological disorders, such as Alzheimer's disease, Parkinson's disease, schizophrenia, bipolar disorder, major depressive disorders, substance use disorders, human immunodeficiency virus-associated neurocognitive disorder, and cancer/treatment-induced neurodegeneration. These studies have focused on the isolation and cargo characterization of either total EVs or brain cells, such as neuron-, astrocyte-, microglia-, oligodendrocyte-, pericyte-, and endothelial-derived EVs from biofluids to achieve early diagnosis and molecular characterization and to predict the treatment and intervention outcomes. The findings of these studies have demonstrated that EVs could serve as a repetitive and less invasive source of valuable molecular information for these neurological disorders, supplementing existing costly neuroimaging techniques and relatively invasive measures, like lumbar puncture. However, the initial excitement surrounding blood-based biomarkers for brain-related diseases has been tempered by challenges, such as lack of central nervous system specificity in EV markers, lengthy protocols, and the absence of standardized procedures for biological sample collection, EV isolation, and characterization. Nevertheless, with rapid advancements in the EV field, supported by improved isolation methods and sensitive assays for cargo characterization, brain cell-derived EVs continue to offer unparallel opportunities with significant translational implications for various neurological disorders. SIGNIFICANCE STATEMENT: Extracellular vesicles present a less invasive liquid biopsy approach in the diagnosis and prognosis of various neurological disorders. Characterizing these vesicles in biofluids holds the potential to yield valuable molecular information, thereby significantly impacting the development of novel biomarkers for various neurological disorders. This paper has reviewed the methodology employed to isolate extracellular vesicles derived from various brain cells in biofluids, their utility in enhancing the molecular understanding of neurodegeneration, and the potential challenges in this research field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderExtracellular VesiclesAlzheimer DiseaseHumansLiquid BiopsyBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Departments of Cancer Biology (A.K., G.D.), Physiology and Pharmacology (M.A.N.), Radiology (M.A.N.), and Center for Addiction Research (M.A.N., G.D.), Wake Forest University School of Medicine, Winston-Salem, North Car…

Förderung

  • NIDA NIH HHS
  • NIA NIH HHS

Zitieren

APA

Kumar, A., Nader, M. A., & Deep, G. (2024). Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust. Pharmacological Reviews, 76(2), 199-227. https://doi.org/10.1124/pharmrev.122.000788

Vancouver

Kumar A, Nader MA, Deep G. Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust. Pharmacological Reviews. 2024;76(2):199-227. doi:10.1124/pharmrev.122.000788

BibTeX
@article{Kumar2024,
  author = {Kumar, Ashish and Nader, Michael A and Deep, Gagan},
  title = {Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust},
  journal = {Pharmacological Reviews},
  year = {2024},
  volume = {76},
  number = {2},
  pages = {199--227},
  doi = {10.1124/pharmrev.122.000788}
}
Kostenlos starten →